Steroid therapy for a case of severe drug-induced cholestasis

Annals of Pharmacotherapy

Volumn 40, Issue 6, 2006, Pages 1196-1199

  Giannattasio, Antonietta ^a   D'Ambrosi, Mariangela ^a   Volpicelli, Monica ^a   Iorio, Raffaele ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Corticosteroid therapy; Drug induced hepatotoxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLARITHROMYCIN; CORTICOSTEROID; GAMMA GLUTAMYLTRANSFERASE; NIMESULIDE; PREDNISONE; URSODEOXYCHOLIC ACID;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHOLESTASIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; STEROID THERAPY; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLESTASIS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS, TOXIC; HUMANS; LIVER; LIVER FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; SULFONAMIDES;

EID: 33745067509     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G345     Document Type: Article

References (22)

1. George DK, Crawford D. Antibacterial-induced hepatotoxicity. Incidence, prevention, and management. Drug Safety 1996;15:79-85.
2. Kaplowits N. Drug-induced liver injury. Clin Infect Dis 2004;38(suppl):S44-8.
3. Larrey D. Drug-induced liver diseases. J Hepatol 2000;32:77-88.
4. Brown BA, Wallace RJ Jr, Griffith DE, Girard W. Clarithromycin-induced hepatotoxicity. Clin Infect Dis 1995;20:1073-4.
5. Fox JC, Szyjkowski RS, Sanderson SO, Levine RA. Progressive cholestatic liver disease associated with clarithromycin treatment. J Clin Pharmacol 2002;42:676-80.
6. Tietz A, Heim MH, Eriksson U, Marsch S, Terracciano L, Krahenbuhl S. Fulminant liver failure associated with clarithromycin. Ann Pharmacother 2003;37:57-60. DOI 10.1345/aph 1C171
7. Boesterli UA. Mechanism of NSAID -induced hepatotoxicity: focus on nimesulide. Drug Saf 2002;25:633-48.
8. Sbeit W, Krivoy N, Shiller M, et al. Nimesulide-induced acute hepatitis. Ann Pharmacother 2001;35:1049-52.
9. Van Steenbergen W, Peeters P, De Bondt J, et al. Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol 1998;29:135-41.
10. Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002;87:462-6.
11. Morales-Diaz M, Pinilla-Roa E, Ruiz I. Suspected carbamazepine-induced hepatotoxicity. Pharmacotherapy 1999;19:252-5.
12. Krowchuk D, Seashore JH. Complete biliary obstruction due to erythromycin estolate administration in an infant. Pediatrics 1979;64:956-8.
13. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26:47-51.
14. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003;31:474-85.
15. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drag reactions. Clin Pharmacol Ther 1981;30:239-45.
16. Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B. Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics 1999;104:1251-7.
17. Chandrupatla S, Demetris AJ, Rabinovitz M. Azithromycin-induced intrahepatic cholestasis. Dig Dis Sci 2002;47:2186-8.
18. O'Grady JG. Paracetamol-induced acute liver failure: prevention and management. J Hepatol 1997;26:41-6.
19. Chitturi S, Farrell GC. Drug-induced liver disease. Curr Treat Options Gastroenterol 2000;3:457-62.
20. Velayudham LS, Farrell GC. Drug-induced cholestasis. Expert Opin Drug Saf 2003;2:287-304.
21. Alberti L, Alberti-Flor JJ. Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids (letter). Am J Gastroenterol 2002;97:1072.
22. Giordano N, Nardi P, Santacroce C, Geraci S, Gennari C. Acute hepatitis induced by cyproterone acetate. Ann Pharmacother 2001;35:1053-5.